STOCK TITAN

BrightSpring Health Services, Inc. Tangible Equity Unit (BTSGU) Financials

BTSGU
Trailing 12 months to June 30, 2026
Revenue $14.4B +33.2% YoY
Net Income $364.4M +250.1% YoY
EPS (Diluted) $1.66 +418.8% YoY
Free Cash Flow $402.4M +110.5% YoY
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Jul 31, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the BTSGU SEC filings page.

BrightSpring Health Services, Inc. Tangible Equity Unit (BTSGU) reported $14.4B in revenue over the twelve months to Jun 30, 2026, up 33.2% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 4 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI BTSGU FY2025

Revenue scale is widening operating leverage while lower gross margins and falling debt costs reshape earnings quality.

Revenue rose from $7.7B in FY2023 to $12.9B in FY2025, creating a much larger base for fixed costs to absorb. Operating margin expanded to 2.3% even as gross margin compressed to 11.8%, indicating SG&A was absorbing scale faster than gross economics deteriorated.

FY2025 net income of $189M converted into operating cash flow of $490M, showing that the earnings rebound was accompanied by cash generation rather than resting only on accounting results. Positive free cash flow after capital spending reinforces that conversion.

Debt-to-equity fell from 5.7x in FY2023 to 1.3x in FY2025, reducing the balance sheet's reliance on creditors. The current ratio rose from 1.2x to 1.6x over the same span, so improving short-term liquidity accompanied deleveraging.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score not available

BrightSpring Health Services, Inc. Tangible Equity Unit does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Strong
7/9

BrightSpring Health Services, Inc. Tangible Equity Unit passes 7 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 2 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed
2.59x

For every $1 of reported earnings, BrightSpring Health Services, Inc. Tangible Equity Unit generates $2.59 in operating cash flow ($490.2M OCF vs $189.1M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage At Risk
1.88x

BrightSpring Health Services, Inc. Tangible Equity Unit earns $1.88 in operating income for every $1 of interest expense ($295.3M vs $157.3M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$3.9B
YoY+23.0%
QoQ+7.2%

BrightSpring Health Services, Inc. Tangible Equity Unit generated $3.9B in revenue in Q2 2026. This represents an increase of 23.0% from the same quarter a year earlier. Against the prior quarter it is up 7.2%.

EBITDA
$171.8M
YoY+90.1%
QoQ+7.0%

BrightSpring Health Services, Inc. Tangible Equity Unit's EBITDA was $171.8M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 90.1% from the same quarter a year earlier. Against the prior quarter it is up 7.0%.

Net Income
$84.3M
YoY+198.8%
QoQ-43.3%

BrightSpring Health Services, Inc. Tangible Equity Unit reported $84.3M in net income in Q2 2026. This represents an increase of 198.8% from the same quarter a year earlier. Against the prior quarter it is down 43.3%.

EPS (Diluted)
$0.38
YoY+192.3%
QoQ-43.3%

BrightSpring Health Services, Inc. Tangible Equity Unit earned $0.38 per diluted share (EPS) in Q2 2026. This represents an increase of 192.3% from the same quarter a year earlier. Against the prior quarter it is down 43.3%.

Cash & Balance Sheet

Free Cash Flow
$14.9M
YoY-39.6%
QoQ-85.3%

BrightSpring Health Services, Inc. Tangible Equity Unit generated $14.9M in free cash flow in Q2 2026, representing cash available after capex. This represents a decrease of 39.6% from the same quarter a year earlier. Against the prior quarter it is down 85.3%.

Cash & Debt
$550.4M
YoY+685.5%
QoQ-38.1%

BrightSpring Health Services, Inc. Tangible Equity Unit held $550.4M in cash against $2.1B in long-term debt as of Q2 2026.

Shares Outstanding
198M
YoY+11.7%
QoQ+2.0%

BrightSpring Health Services, Inc. Tangible Equity Unit had 198M shares outstanding in Q2 2026. This represents an increase of 11.7% from the same quarter a year earlier. Against the prior quarter it is up 2.0%.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Gross Margin
12.7%
YoY+0.8pp
QoQ-0.6pp

BrightSpring Health Services, Inc. Tangible Equity Unit's gross margin was 12.7% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 0.8 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.6 percentage points.

Operating Margin
3.4%
YoY+1.8pp
QoQ0.0pp

BrightSpring Health Services, Inc. Tangible Equity Unit's operating margin was 3.4% in Q2 2026, reflecting core business profitability. This is up 1.8 percentage points from the same quarter a year earlier. It is unchanged from the prior quarter.

Net Margin
2.2%
YoY+1.3pp
QoQ-1.9pp

BrightSpring Health Services, Inc. Tangible Equity Unit's net profit margin was 2.2% in Q2 2026, showing the share of revenue converted to profit. This is up 1.3 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.9 percentage points.

Return on Equity
4.1%
YoY+2.5pp
QoQ-3.4pp

BrightSpring Health Services, Inc. Tangible Equity Unit's ROE was 4.1% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 2.5 percentage points from the same quarter a year earlier. Against the prior quarter it is down 3.4 percentage points.

Capital Allocation

Share Buybacks
$60.0M
QoQ0.0%

BrightSpring Health Services, Inc. Tangible Equity Unit spent $60.0M on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding. It is unchanged from the prior quarter.

Capital Expenditures
$29.0M
YoY+18.9%
QoQ+34.8%

BrightSpring Health Services, Inc. Tangible Equity Unit invested $29.0M in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 18.9% from the same quarter a year earlier. Against the prior quarter it is up 34.8%.

R&D Spending

Not reported for Q2 2026.

BTSGU Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

BTSGU quarterly income statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Revenue$3.9B+23.0%$3.6B+25.6%$3.6B+91.0%$3.3B+14.7%$3.1B+15.3%$2.9B+11.7%$1.9B+50.0%$2.9B+28.8%
Cost of RevenueN/AN/AN/AN/AN/AN/AN/A$2.5B+31.6%
Gross Profit$492.7M+31.5%$482.2M+42.5%$412.5M+21.8%$392.0M+21.3%$374.9M+20.1%$338.4M+15.7%$338.7M+358.2%$323.1M-9.8%
SG&A Expenses$362.4M+11.1%$360.8M+25.4%$304.4M+7.5%$304.2M+3.5%$326.3M+19.3%$287.6M-6.6%$283.1M+198.9%$294.0M-28.4%
Operating Income$130.4M+168.5%$121.4M+139.4%$108.1M+94.7%$87.8M+201.9%$48.6M+25.6%$50.7M+430.9%$55.5M+367.1%$29.1M+155.7%
EBITDA$171.8M+90.1%$160.5M+72.8%$147.6M+33.7%$128.6M+61.3%$90.4M+1.9%$92.9M+176.6%$110.4M+265.4%$79.7M+5489.1%
Interest Expense$36.9M-4.9%$38.6M-7.5%$38.5M-16.6%$38.2M-18.0%$38.8M-10.4%$41.8M-23.3%$46.2M+52.1%$46.6M-44.3%
Income Tax$6.9M+458.0%$8.6M+3662.9%$20.0M+294.5%$12.1M+48.6%$1.2M+109.4%-$240K+99.1%$5.1M+127.4%$8.2M+240.4%
Net Income$84.3M+198.8%$148.8M+403.6%$75.5M+38.4%$55.8M+778.4%$28.2M+41.6%$29.5M+164.6%$54.6M+935.0%-$8.2M+93.7%
EPS (Basic)$0.41+192.9%$0.73+386.7%$0.38+322.2%$0.27+775.0%$0.14+40.0%$0.15+157.7%$0.09+280.0%-$0.04+96.4%
EPS (Diluted)$0.38+192.3%$0.67+378.6%$0.35$0.26+750.0%$0.13+30.0%$0.14+153.8%$0.09-$0.04
Diluted Shares (Avg)220M+1.8%221M+3.0%N/A218M+9.8%216M+3.5%215M+22.4%N/A198M

Not reported in any period shown, so not listed: R&D Expenses.

BTSGU Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

BTSGU quarterly balance sheet
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Total Assets$6.0B+0.7%$6.2B+6.3%$6.4B+8.2%$6.0B+4.6%$5.9B+6.0%$5.8B+3.4%$5.9B+7.1%$5.8B
Current Assets$2.5B-6.7%$2.7B+6.4%$2.9B+52.9%$2.8B+62.6%$2.6B+74.0%$2.5B+60.8%$1.9B+30.0%$1.7B
Cash & Equivalents$550.4M+685.5%$888.8M+1598.2%$88.4M+45.0%$140.3M+290.1%$70.1M+180.0%$52.3M-9.8%$61.0M+390.4%$36.0M
Short-Term Investments$0$0$0$0$0$0$0$0
Inventory$575.0M-8.1%$560.2M+5.0%$815.2M+28.1%$639.2M+33.6%$625.5M+67.1%$533.6M+42.8%$636.6M+59.6%$478.3M
Accounts Receivable$1.1B+17.1%$1.1B+14.2%$989.7M+9.6%$1.0B-1.2%$972.7M-1.2%$975.3M-1.5%$902.8M+17.7%$1.0B
Long-Term Investments$7.5M$7.5M$7.5M+424.2%$0$0$0$1.4M$0
Goodwill$2.5B+7.0%$2.5B+6.9%$2.5B+7.7%$2.4B-11.3%$2.4B-9.8%$2.4B-9.2%$2.4B+2.7%$2.7B
Total Liabilities$3.9B-6.4%$4.2B+1.6%$4.5B+5.9%$4.2B+1.5%$4.2B+5.0%$4.2B+1.8%$4.3B-13.1%$4.2B
Current Liabilities$1.6B+3.3%$1.5B+6.2%$1.8B+29.5%$1.5B+22.6%$1.5B+31.5%$1.5B+17.1%$1.4B+14.4%$1.3B
Non-Current Liabilities$2.4B-11.9%$2.7B-0.9%$2.7B-5.9%$2.7B-7.7%$2.7B-5.7%$2.7B-4.8%$2.8B-22.5%$2.9B
Long-Term Debt$2.1B-13.3%$2.4B-1.8%$2.5B-4.2%$2.5B-5.5%$2.5B-3.3%$2.5B-1.0%$2.6B-23.1%$2.6B
Total Equity$2.0B+17.5%$2.0B+17.3%$1.9B+13.8%$1.8B+12.6%$1.7B+9.0%$1.7B+7.6%$1.6B+181.8%$1.6B+155.7%
Retained Earnings$38.4M+123.4%$14.1M+107.3%-$74.6M+66.4%-$108.6M+53.7%-$164.4M+27.3%-$192.6M+21.7%-$222.2M-10.9%-$234.4M

BTSGU Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

BTSGU quarterly cash flow statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Operating Cash Flow$43.9M-10.5%$122.9M+21.0%$231.6M+155.6%$107.9M+296.2%$49.1M+422.3%$101.6M+228.8%$90.6M-44.2%$27.2M-19.1%
Depreciation & Amortization$41.4M-1.0%$39.1M-7.3%$39.5M-28.0%$40.8M-19.5%$41.8M-16.4%$42.2M-13.8%$54.9M+7.6%$50.6M-0.3%
Stock-Based CompensationN/A$3.7M-76.6%N/AN/AN/A$15.7M-36.9%N/AN/A
Capital Expenditures$29.0M+18.9%$21.5M+22.2%$37.7M+146.0%$15.8M-21.4%$24.4M+2.9%$17.6M-19.2%$15.3M-9.0%$20.0M+12.0%
Free Cash Flow$14.9M-39.6%$101.4M+20.8%$193.9M+157.5%$92.2M+1179.7%$24.7M+163.3%$84.0M+183.4%$75.3M-48.3%$7.2M-54.4%
Investing Cash Flow-$28.2M-21.3%$747.4M+3189.5%-$233.9M-1382.2%-$23.8M+33.7%-$23.2M+59.7%-$24.2M+21.8%-$15.8M+7.3%-$35.8M+34.4%
Financing Cash Flow-$354.1M-4196.2%-$70.0M+18.6%-$50.5M-1.9%-$13.1M-167.1%-$8.2M-120.7%-$86.0M-155.6%-$49.6M+65.6%$19.5M-8.5%
Share Buybacks$60.0M$60.0MN/AN/AN/AN/A$0-100.0%$0

Not reported in any period shown, so not listed: Dividends Paid.

BTSGU Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

BTSGU quarterly financial ratios
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Gross Margin12.7%+0.8pp13.3%+1.6pp11.6%-6.6pp11.8%+0.6pp11.9%+0.5pp11.8%+0.4pp18.2%+12.3pp11.1%-4.8pp
Operating Margin3.4%+1.8pp3.4%+1.6pp3.0%+0.1pp2.6%+1.6pp1.5%+0.1pp1.8%+2.4pp3.0%+4.7pp1.0%+3.3pp
Net Margin2.2%+1.3pp4.1%+3.1pp2.1%-0.8pp1.7%+1.9pp0.9%+0.2pp1.0%+2.8pp2.9%+3.5pp-0.3%+5.5pp
Return on Equity4.1%+2.5pp7.5%+5.8pp4.0%+0.7pp3.1%+3.6pp1.6%+0.4pp1.8%+4.7pp3.3%+4.4pp-0.5%+20.2pp
Return on Assets1.4%+0.9pp2.4%+1.9pp1.2%+0.3pp0.9%+1.1pp0.5%+0.1pp0.5%+1.3pp0.9%+1.0pp-0.1%
Current Ratio1.59-0.2x1.740.0x1.57+0.2x1.79+0.4x1.76+0.4x1.73+0.5x1.33+0.2x1.35
Debt-to-Equity1.05-0.4x1.24-0.2x1.31-0.2x1.36-0.3x1.42-0.2x1.48-0.1x1.55-4.1x1.62
Asset Turnover0.65+0.1x0.58+0.1x0.55+0.2x0.550.0x0.530.0x0.490.0x0.31+0.1x0.50
FCF Margin0.4%-0.4pp2.8%-0.1pp5.5%+1.4pp2.8%+2.5pp0.8%+2.2pp2.9%+6.8pp4.0%-7.7pp0.3%-0.5pp

Frequently Asked Questions

What is BrightSpring Health Services, Inc. Tangible Equity Unit's annual revenue?

BrightSpring Health Services, Inc. Tangible Equity Unit (BTSGU) reported $12.9B in total revenue for fiscal year 2025. This represents a 28.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is BrightSpring Health Services, Inc. Tangible Equity Unit's revenue growing?

BrightSpring Health Services, Inc. Tangible Equity Unit (BTSGU) revenue grew by 28.2% year-over-year, from $10.1B to $12.9B in fiscal year 2025.

Is BrightSpring Health Services, Inc. Tangible Equity Unit profitable?

Yes, BrightSpring Health Services, Inc. Tangible Equity Unit (BTSGU) reported a net income of $189.1M in fiscal year 2025, with a net profit margin of 1.5%.

BrightSpring Health Services, Inc. Tangible Equity Unit (BTSGU) reported diluted earnings per share of $0.87 for fiscal year 2025. This represents a 1066.7% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

BrightSpring Health Services, Inc. Tangible Equity Unit (BTSGU) had EBITDA of $459.5M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, BrightSpring Health Services, Inc. Tangible Equity Unit (BTSGU) had $88.4M in cash and equivalents against $2.5B in long-term debt.

BrightSpring Health Services, Inc. Tangible Equity Unit (BTSGU) had a gross margin of 11.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

BrightSpring Health Services, Inc. Tangible Equity Unit (BTSGU) had an operating margin of 2.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

BrightSpring Health Services, Inc. Tangible Equity Unit (BTSGU) had a net profit margin of 1.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

BrightSpring Health Services, Inc. Tangible Equity Unit (BTSGU) has a return on equity of 10.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

BrightSpring Health Services, Inc. Tangible Equity Unit (BTSGU) generated $394.7M in free cash flow during fiscal year 2025. This represents a 790.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

BrightSpring Health Services, Inc. Tangible Equity Unit (BTSGU) generated $490.2M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

BrightSpring Health Services, Inc. Tangible Equity Unit (BTSGU) had $6.4B in total assets as of fiscal year 2025, including both current and long-term assets.

BrightSpring Health Services, Inc. Tangible Equity Unit (BTSGU) invested $95.5M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Yes, BrightSpring Health Services, Inc. Tangible Equity Unit (BTSGU) spent $43.2M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

BrightSpring Health Services, Inc. Tangible Equity Unit (BTSGU) had 194M shares outstanding as of fiscal year 2025.

BrightSpring Health Services, Inc. Tangible Equity Unit (BTSGU) had a current ratio of 1.57 as of fiscal year 2025, which is generally considered healthy.

BrightSpring Health Services, Inc. Tangible Equity Unit (BTSGU) had a debt-to-equity ratio of 1.31 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

BrightSpring Health Services, Inc. Tangible Equity Unit (BTSGU) had a return on assets of 2.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

BrightSpring Health Services, Inc. Tangible Equity Unit (BTSGU) has a Piotroski F-Score of 7 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

BrightSpring Health Services, Inc. Tangible Equity Unit (BTSGU) has an earnings quality ratio of 2.59x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

BrightSpring Health Services, Inc. Tangible Equity Unit (BTSGU) has an interest coverage ratio of 1.88x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Back to top